InspireMD (NSPR) Capital Expenditures Growth (1y) (2011 - 2025)
InspireMD (NSPR) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -47.73% |
| 10 | InspireMD | 43.74 Mn | -10.47 Mn | 1.18 Mn | 27.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.97% |
| Sep 30, 2025 | -21.85% |
| Jun 30, 2025 | 21.26% |
| Mar 31, 2025 | 84.10% |
| Dec 31, 2024 | 44.65% |
| Sep 30, 2024 | 338.54% |
| Jun 30, 2024 | 955.56% |
| Mar 31, 2024 | 680.00% |
| Dec 31, 2023 | 126.32% |
| Sep 30, 2023 | -57.52% |
| Jun 30, 2023 | -60.87% |
| Mar 31, 2023 | -32.43% |
| Dec 31, 2022 | -11.21% |
| Sep 30, 2022 | 43.95% |
| Jun 30, 2022 | 112.96% |
| Mar 31, 2022 | 42.31% |
| Dec 31, 2021 | 72.58% |
| Dec 31, 2020 | 16.98% |
| Dec 31, 2019 | 43.24% |
| Sep 30, 2019 | 3,200.00% |